PLEASE NOTE ! AS A PERISHABLE PRODUCT, THIS ITEM MUST BE SHIPPED BY FED EX AIR ONLY !
Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine, Modified Live Virus
- High antigenic mass (titer), low passage parvovirus vaccine.
- Canine vaccine containing parvovirus type 2b, the most prevalent field strain of parvovirus.
- Canine parvovirus type 2b protects against all fields strains curremtly seen.
- Overrides maternal antibodies in young puppies. Primary vaccination may begin as early as 6 weeks. Last dose may be given at 12 weeks of age.
- No reversion to virulence.
- Onderstepoort-type distemper strain, proven efficacious for over 50 years.
Dosage and Administration: Inject one dose (1 mL) subcutaneously or intramuscularly. The initial dose may be given at 6 weeks of age or older. Repeat at 2 to 4 week intervals until the dog is 12 weeks of age. A minimum of two doses is required for primary immunization. Annual revaccination with one dose is recommended.
Transfer contents of the sterile diluent vial to the GALAXY DA2PPv vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.
Contraindication(s): Do not vaccinate pregnant bitches.
Precaution(s): Do not freeze. Use new, non-chemically sterilized, needles and syringes. Do not mix with other vaccines. Burn vaccine container and all unused contents.
Caution(s): Vaccinate only healthy, non-parasitized dogs.
The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.
The age at which maternal antibodies for canine parvovirus no longer interferes with the development of active immunity and varies according to the bitch's titer and quantity of colostral antibodies absorbed by the puppy.
Antidote(s): Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
